Search for: "Endo Pharmaceutical" Results 21 - 40 of 255
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2021, 12:15 pm by Simmons Hanly Conroy
After six long months, the once-sprawling case has seen a number of key results in favor of plaintiffs, including: Former opioid manufacturer Allergan agreed to a $200 million settlement with New York State and Suffolk and Nassau Counties Endo Pharmaceuticals and its subsidiaries agreed to a settlement with New York State, and Suffolk and Nassau Counties, totaling $50 million Johnson & Johnson settled with the state of New York for $230 million, and as part of their agreement,… [read post]
7 Nov 2021, 9:31 am by Professor Alberto Bernabe
  The defendants included Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie Inc. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
As the sprawling New York State opioid trial heads into the last week of October, attention has shifted toward a court-commissioned referee report recommending sanctions against the defense law firm Arnold & Porter Kaye Scholer (APKS), which represented Endo Pharmaceuticals in the ongoing case. [read post]
28 Oct 2021, 7:40 am by Simmons Hanly Conroy
As the sprawling New York State opioid trial heads into the last week of October, attention has shifted toward a court-commissioned referee report recommending sanctions against the defense law firm Arnold & Porter Kaye Scholer (APKS), which represented Endo Pharmaceuticals in the ongoing case. [read post]
21 Oct 2021, 9:50 am by Simmons Hanly Conroy
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva… [read post]
16 Sep 2021, 12:57 pm by Simmons Hanly Conroy
In its settlement with the state and counties, Endo and its subsidiaries, including Par Pharmaceutical, have been severed from the trial. [read post]
7 Sep 2021, 2:35 pm by Simmons Hanly Conroy
The post In the News: New York State Files Motion Asking Judge to Render Default Judgement Against Endo Pharmaceuticals appeared first on Simmons Hanly Conroy. [read post]
2 Sep 2021, 3:38 pm by Simmons Hanly Conroy
  Defendants remaining in the trial are manufacturers Allergan, Teva Pharmaceutical Industries, Endo International and distributor Anda. [read post]
16 Aug 2021, 6:32 am by Robert Kraft
” Furthermore, drugmakers AbbVie, Teva, and Endo are also missing from the settlement even though they “have been accused of misleadingly marketing their pain medicines as safe. [read post]
10 Aug 2021, 6:20 am by Robert Kraft
” With the “settlements, only three drug manufacturers, Endo Health Solutions, Teva Pharmaceuticals USA and Allergan Finance, remain at trial. [read post]
30 Jul 2021, 7:01 am by Simmons Hanly Conroy
The New York State opioid trial continues against three major drugmakers, Endo International Plc., Teva Pharmaceutical Industries Ltd., and AbbVie Inc’s Allergan unit, which all stand accused of having deceptively marketed their opioid painkillers. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
16 Apr 2021, 5:52 am by Sara E. Teller
Endo Pharmaceuticals keep important evidence out of discovery. [read post]
9 Dec 2020, 2:13 pm by Kevin LaCroix
In 2018, cases revolving around consequences of the #MeToo movement and the opioid crisis increased, while 2019 saw an increase in filings alleging cyber security breaches and environmental disasters. 2020 has been no exception; now, amid a global pandemic, new filings are occurring based upon the fallout from the Coronavirus and its impact on certain economic industries, such as cruise lines and pharmaceutical companies. [read post]
6 Oct 2020, 7:55 pm by Lisa Baird
As part of the Greater Philadelphia chapter of the Association of Corporate Counsel’s Litigation Law CLE Week, I am pleased to be joining my Reed Smith colleague Jim Beck and Endo Pharmaceuticals’ Vice President and Assistant General Counsel – Litigation and Risk Jobina Jones-McDonnell to present a 12 p.m. [read post]
19 Feb 2020, 8:24 pm by Pete Strom
On Thursday, June 20th, Endo Pharmaceuticals – the transvaginal mesh subsidiary of AMS – offered $54.5 million to settle several of the personal injury claims. [read post]
24 Dec 2019, 6:00 am by Robert Kraft
” The DEA database “attributes the vast majority of the 76 billion opioid pills produced and shipped from 2006 through 2012 to three companies that are now controlled by large multinational drugmakers: SpecGx, a subsidiary of Ireland-based Mallinckrodt; Par Pharmaceutical, owned by Endo Pharmaceuticals, also in Ireland; and Actavis, part of Israel-based Teva Pharmaceutical Industries. [read post]